New Research Aims to Help the Immune System Accept Transplanted Insulin-Producing Cells

Pancreatic islet transplantation—transferring insulin-producing cells into a person with Type 1 diabetes—is a promising approach. However, the immune system often attacks these new cells because it recognizes them as foreign. This rejection is a major barrier to making transplantation a practical option for more people.

If researchers can teach the immune system to accept transplanted islets without suppressing overall immune function, it could expand access to this therapy and reduce the need for lifelong immunosuppressive drugs.

LyGenesis, a biotechnology company, has received a research award from Breakthrough T1D to explore a novel strategy: using the thymus to induce immune tolerance to transplanted pancreatic islets.

The thymus is a small organ that plays a central role in immune development. It trains immune cells called T cells to distinguish between the body's own cells and foreign invaders. By understanding and leveraging thymic biology, researchers hope to reprogram the immune system to accept new islet cells.

The research is led by Dr. Eric Lagasse, a professor of pathology at the University of Pittsburgh and Chief Scientific Officer at LyGenesis. His work has established important principles about how the thymus functions and how immune cells can be reprogrammed.

This new project is currently in the pre-clinical phase, meaning it is being tested in the laboratory and has not yet advanced to human trials. The research aims to build a foundation for future studies that could, eventually, be tested in people with Type 1 diabetes.

If successful, this approach could address one of the biggest obstacles to islet transplantation: preventing the immune system from rejecting the transplanted cells. Success would not immediately transform treatment, but it represents the kind of foundational research needed to make transplantation more viable and accessible.

The research also reflects growing scientific interest in the thymus and its role not only in immune tolerance but in broader health and immune function throughout life.

Origin: finance.yahoo.com (News report). Evidence: News report — unverified, pending corroboration. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.